Omówienie artykułu: Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.
Glatt S., Jemec G.B.E., Forman S. i wsp.
JAMA Dermatol. 2021 Aug 18:e212905. Epub ahead of print.